类风湿关节炎患者基线及抗肿瘤坏死因子治疗4周时关节摄取的SUV与动态药代动力学[18F]氟-聚乙二醇-叶酸参数比较
本研究对6例类风湿关节炎患者共11次动态[18F]氟-聚乙二醇-叶酸PET/CT扫描(治疗前6次、治疗后5次)进行药代动力学建模,发现可逆性二室模型拟合最佳,分布容积VT均值为1.0(±0.5);VT与30-60分钟和40-60分钟简化的SUV间隔相关,可在显像时无需完整药代动力学评估即可量化示踪剂摄取。
要点
- 可逆性二室药代动力学模型最适合描述类风湿关节炎患者关节[18F]氟-聚乙二醇-叶酸动力学。
- 动脉与静脉样本VT值在基线和抗肿瘤坏死因子治疗4周后均相关。
- VT与30-60分钟简化SUV间隔的关联支持无需完整药代动力学评估即可量化摄取。
核心结论
- 类风湿关节炎患者关节[18F]氟-聚乙二醇-叶酸摄取的最优动力学模型为可逆性二室模型。
- VT与30-60分钟简化SUV间隔的关联允许在显像时无需完整横断面药代动力学评估即可量化示踪剂摄取。
- 需进一步研究以准确评估时间点之间示踪剂行为的变化及简化评估关节示踪剂摄取随时间变化的应用。
研究设计与样本
- 研究纳入6例类风湿关节炎患者,共进行11次动态[18F]氟-聚乙二醇-叶酸PET/CT扫描,其中治疗前6次、治疗后5次。
- 采用常规药代动力学模型分析动态扫描数据。
- 计算注射后10-40、20-50、30-60和40-60分钟间隔的SUV用于比较和显像时间窗优化。
主要发现
- 关节[18F]氟-聚乙二醇-叶酸动力学最佳由可逆性二室药代动力学模型描述,分布容积VT均值为1.0(±0.5)。
- 动脉与静脉样本VT值在基线(P < 0.001,r² = 0.96)和抗肿瘤坏死因子治疗4周后(P < 0.001,r² = 0.75)均相关,且在30-60分钟和40-60分钟间隔均相关。
- 由于可用数据有限,治疗期间VT行为的变化无法准确评估,但观察到的线性关联斜率变化可能提示动力学行为改变。
关键数值与推荐
- 最优动力学模型为可逆性二室模型。
- VT均值1.0(±0.5)。
- 动脉与静脉样本VT相关性:基线P < 0.001,r² = 0.96;治疗4周后P < 0.001,r² = 0.75。
- 简化SUV间隔30-60分钟与VT相关。
临床怎么用
- 原文结论指出,VT与30-60分钟简化SUV间隔的关联允许在显像时无需完整横断面药代动力学评估即可量化示踪剂摄取。
- 原文结论指出,需进一步研究以准确评估时间点之间示踪剂行为的变化及简化评估关节示踪剂摄取随时间变化的应用。
局限性
- 由于可用数据有限,治疗期间VT行为的变化无法准确评估。
- 需进一步研究以准确评估时间点之间示踪剂行为的变化及简化评估关节示踪剂摄取随时间变化的应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Quantitative assessment of rheumatoid arthritis (RA) activity using [18F]fluoro-polyethylene glycol (PEG)-folate PET/CT scans may prove a useful noninvasive therapeutic response assessment tool to evaluate antitumor necrosis factor therapy in RA patients. This study aims to assess [18F]fluoro-PEG-folate kinetics through a metabolite-corrected plasma input model and to investigate comparisons with simplified quantitative PET outcome measures. Methods: Dynamic [18F]fluoro-PEG-folate PET/CT scans were obtained for 6 patients for a total of 11 scans, 6 before and 5 after treatment. These scans were analyzed using conventional pharmacokinetic models. In addition, SUVs were calculated at intervals of 10-40, 20-50, 30-60, and 40-60 min after injection for comparison and imaging window optimization. Results: [18F]fluoro-PEG-folate kinetics in joints of RA patients were best described using the reversible pharmacokinetic 2-tissue compartment model with a volume of distribution (VT ) mean of 1.0 (±0.5). VT values correlated between arterial and venous samples at both baseline (P < 0.001, r 2 = 0.96) and 4 wk after antitumor necrosis factor treatment (P < 0.001, r 2 = 0.75), both at intervals of 30-60 and 40-60 min. Changes in VT behavior during treatment could not be accurately assessed because of limited available data, but observed changes in the linear association slope may indicate changed kinetic behavior. Conclusion: The most optimal kinetic model for [18F]fluoro-PEG-folate uptake in joints of RA patients was the reversible 2-tissue compartment model. The associations between VT and a simplified SUV interval of 30-60 min allow us to quantify tracer uptake without the need for a full cross-sectional pharmacokinetic evaluation at the time of imaging. Further research will be required to accurately assess the change in tracer behavior between time points and the use of simplified assessment of changes of tracer uptake in joints over time.
引用
- van Binsbergen WH, Zwezerijnen GJC, Windhorst AD, et al. SUVs Versus Dynamic Pharmacokinetic [18F]Fluoro-Polyethylene Glycol-Folate Uptake Parameters in Joints of Rheumatoid Arthritis Patients at Baseline and at 4 Weeks of Antitumor Necrosis Factor Therapy. J Nucl Med. 2025. PMID: 40610230. doi:10.2967/jnumed.124.268717
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。